Altamira Therapeutics announced the pricing of a public offering of 11,111,112 common shares accompanied by common warrants to purchase up to 11,111,112 common shares, at a combined public offering price of $0.45 per share and accompanying common warrant. The common warrants will have an exercise price of $0.45 per share, will be immediately exercisable upon issuance and will expire five years from the date of issuance. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CYTO:
- Altamira Therapeutics enters collaboration, option agreement with Heqet
- Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration
- Altamira Therapeutics files to sell common shares, no amount given
- Altamira announces FDA clearance of IND for AM-125
- One new option listing and option delistings on June 15th